Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Exagen Inc.
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
March 18, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 08, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
March 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Third Quarter 2023 Results
November 13, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
November 09, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 02, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
October 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
September 28, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Second Quarter 2023 Results
August 07, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
July 25, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
FLGT
XGN
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports First Quarter 2023 Results
May 15, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Campaign for Lupus Awareness Month
May 01, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
April 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
March 20, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
March 06, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in Upcoming March Conferences
February 27, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
January 23, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
AZTA
VCYT
XGN
Exagen Inc. Reports Third Quarter 2022 Results
November 14, 2022
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 08, 2022
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
October 31, 2022
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Appointment of John Aballi as CEO
October 17, 2022
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
October 04, 2022
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.